Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 217–227 of 227 articles · Keyword: Polymeric Clear keyword

Journal of Biological Chemistry2001ResearchNon-viral Gene Delivery

217. Biological Properties of Poly-l-lysine-DNA Complexes Generated by Cooperative Binding of the Polycation

Ge Liu, Maria Molas, Gregory A. Grossmann, Murali Pasumarthy, Jose C. Perales, Mark J. Cooper, Richard W. Hanson

Receptor-mediated gene transfer using ligand–poly-L-lysine–DNA complexes requires DNA to be condensed into small particles for efficient cellular uptake and expression. However, the relationship between NaCl concentration, the mode of poly-L-lysine binding to DNA, the resulting condensed DNA structure, and…

Read the article
Gene Therapy2001ResearchNon-viral Gene Delivery

218. Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine

Primary lymphoid cells, especially human peripheral blood mononuclear cells (PBMC), are very difficult to transfect with viral and nonviral vectors. There is a need for efficient nonviral, receptor-mediated gene delivery to PBMC for cell-based therapies and for studying gene function in primary lymphocytes. Naive vs…

Read the article
2001ReviewNon-viral Gene Delivery

219. Design and gene delivery activity of modified polyethylenimines

Kircheis, R.; Wightman, L.; Wagner, E

PEI is one of the most effective non-viral gene delivery polymers, but its efficacy, toxicity, and in vivo behaviour depend strongly on molecular weight, branching, particle size, surface charge, and modifications. This review addresses how PEI/DNA complexes can be modified with targeting ligands, shielding agents…

Read the article
Gene Therapy1999ResearchNon-viral Gene Delivery

220. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides

Sérgio Simões, Vladimir Slepushkin, Pedro Pires, Rogério Gaspar, Maria C. Pedroso De Lima & Nejat Düzgüneş

Cationic liposome–DNA complexes (lipoplexes) are safer than viral vectors but have limited transfection efficiency, toxicity at high doses, and sensitivity to serum/extracellular negatively charged macromolecules. The study asks whether targeting ligands or pH-sensitive fusogenic peptides can improve…

Read the article
Journal of Controlled Release1999ResearchNon-viral Gene Delivery

221. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery

Daqing Wang, Deborah R. Robinson, Glen S. Kwon, John Samuel

Naked plasmid DNA vaccination is largely limited to intramuscular, cutaneous, and intradermal routes because naked DNA is ineffective at crossing mucosal barriers and is rapidly degraded by nucleases. Delivery systems that protect plasmid DNA and target it to antigen-presenting cells are needed for mucosal DNA…

Read the article
1999ReviewNon-viral Gene Delivery

222. Poly(ethylenimine) and its role in gene delivery

Godbey, W. T.; Wu, K. K.; Mikos, A. G

Gene therapy still lacks safe and efficient delivery vectors. PEI has emerged as a promising non-viral polycation because it condenses DNA and mediates endosomal escape, but its transfection mechanism, targeting potential, and toxicity require clearer understanding. This review summarises PEI chemistry, PEI/DNA…

Read the article
Journal of Controlled Release1998ResearchNon-viral Gene Delivery

223. Polyethylene Glycol-Grafted Poly-L-Lysine as Polymeric Gene Carrier

Young Hun Choi, Feng Liu, Jin-Seok Kim, Young Kweon Choi, Jong Sang Park, Sung Wan Kim

Non-viral gene delivery systems such as poly-L-lysine (PLL) have low immunogenicity compared with viral vectors, but PLL suffers from poor biocompatibility, rapid degradation, and low transfection efficiency. PEGylation was explored to improve solubility, reduce cytotoxicity, and enhance cell permeability for gene…

Read the article
Molecular Membrane Biology1998ReviewNon-viral Gene Delivery

224. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review)

Hope Mj, Mui B, Ansell S, Ahkong Qf

Polymeric nucleic acid drugs—plasmid DNA, antisense oligonucleotides, and ribozymes—require protection from nucleases and efficient intracellular delivery to cytoplasm/nucleus. Viral vectors are efficient but immunogenic and safety-limited; non-viral cationic lipid systems are promising, but the mechanism of…

Read the article
Gene Therapy1997ResearchNon-viral Gene Delivery

225. In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

S. Li And L. Huang

First-generation cationic liposome–DNA complexes showed insufficient in vivo gene transfer efficiency. A more virus-like, self-assembling non-viral vector was needed that could condense and protect plasmid DNA and produce efficient gene expression after systemic administration. LPD gave consistently higher in vivo…

Read the article
ResearchDrug Delivery

226. Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product

Kevin J. Kauffman, Clement Do, Sadhana Sharma, Matthew D. Gallovic, Eric M. Bachelder, Kristy M. Ainslie

Acetalated dextran (Ac-DEX) is a pH-sensitive, biodegradable polymer useful for drug delivery, but it degrades to methanol, which can be toxic at high concentrations or with repeated dosing. A safer analog that degrades to ethanol instead of methanol is needed for high-volume clinical applications such as multiple…

Read the article
ReviewNon-viral Gene Delivery

227. Delivery of therapeutic nucleic acids via transferrin and transferrin receptors lipoplexes and other carriers

The transferrin receptor (TfR) is overexpressed on many cancer cells and is efficiently internalised, making it a useful target for delivering small-molecule drugs and nucleic acid therapeutics while reducing non-target effects. The review summarises TfR biology, Tf-lipoplex development, and therapeutic applications…

Read the article
Articles — page 10 | Brilliant Blue Biosciences